Who is sponsoring NCT05405140?

NCT05405140 is sponsored by Riphah International University.

What condition does NCT05405140 study?

NCT05405140 studies Stroke, Spasticity, Muscle.

Is NCT05405140 still recruiting?

NCT05405140 is currently completed. Last updated 12 March 2025.

Last reviewed 2025-03-12 · How we verify

NCT05405140

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multiphasic Neuroplasticity Based Training Protocol With Shock Wave Therapy For Post Stroke Spasticity

Completed NA Last updated 12 March 2025

What this trial tests

NA trial testing Shock wave therapy with multiphasic neuroplasticity based training protocol in Stroke in 32 participants. Completed in 15 October 2023.

Timeline

20 May 2022

Primary endpoint
15 August 2023

15 October 2023

Quick facts

Lead sponsor	Riphah International University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	32
Start date	20 May 2022
Primary completion	15 August 2023
Estimated completion	15 October 2023
Sites	1 location across Pakistan

Drugs / interventions tested

Shock wave therapy with multiphasic neuroplasticity based training protocol
Conventional physical therapy

Conditions studied

Stroke — all drugs for Stroke →
Spasticity, Muscle — all drugs for Spasticity, Muscle →

Sponsor

Riphah International University

Who can join

Adults 40 to 70, any sex, with Stroke or Spasticity, Muscle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study will be conducted to f find the effects of multiphasic neuroplasticity based training protocol with Shock Wave Therapy on Neurophysiological, Morphological and Functional Parameters of Post Stroke Spasticity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of Extracorporeal Shockwave Therapy Combined with Neuroplasticity-Based Training Protocol on Lower Limb Spasticity in Stroke Patients: A Randomized Controlled Trial with Ultrasonography Evaluation.
Afzal B, Noor R, Alghwiri AA, Umar A. · · 2026 · PMID 41499331 · DOI 10.1177/10538135251403026

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Riphah International University trials

Trials by the same sponsor.

NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05405140 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Riphah International University
Last refreshed: 12 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05405140.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing